Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01691729 · ClinicalTrials.gov registry record · NA
Comparison Study of 3 Ostomy Products
A NA study of Ostomy, sponsored by ConvaTec.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 4
- Study locations
NCT01691729: Completed NA study of Ostomy, sponsored by ConvaTec.
NCT01691729 is a NA study of Ostomy that has completed, run by ConvaTec. The registered enrollment target is 26 participants, below the 896-participant average among 6 other Ostomy trials with a reported enrollment target (97% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01691729, a NA study of Ostomy, has completed, sponsored by ConvaTec.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 4
- Study locations
Study Summary
To purpose of the study is to evaluate and compare the efficacy of three ostomy accessory products.
Primary Outcome
Evaluation and comparison of the efficacy of three ostomy accessory products in terms of leakage and wear time.
Conditions Studied
Interventions
- DEVICE Ostomy accessory
Study Locations (4)
Arizona
- Independent Nurse Consultants - Tucson
Florida
- ET Nursing Services - Jacksonville
Missouri
- Image Specialties - Saint Joseph
Ohio
- ID MED Inc. - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2012-09 |
| Est. Completion | 2012-11 |
| Phase | NA |
What the finished NCT01691729 record still lists
NCT01691729 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 896-participant average among 6 other Ostomy trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Ostomy appearing as the primary indexed condition, and to 1 intervention - of which Ostomy accessory is the first listed.
NCT01691729 reports a single indexed study location in Arizona, Florida, Missouri.
Frequently Asked Questions
What is clinical trial NCT01691729 about?
NCT01691729 is a clinical study titled "Comparison Study of 3 Ostomy Products". To purpose of the study is to evaluate and compare the efficacy of three ostomy accessory products.
What is the current status of trial NCT01691729?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2012-09. Estimated completion is 2012-11.
What conditions does trial NCT01691729 study?
This clinical trial studies the following conditions: Ostomy.
What interventions are being tested in trial NCT01691729?
The interventions under investigation include: Ostomy accessory (DEVICE).
Who is sponsoring clinical trial NCT01691729?
This trial is sponsored by ConvaTec, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01691729 being conducted?
This trial has 4 study locations across Arizona, Florida, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ostomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
3D Printed Personalized Ostomy Appliance
RECRUITING · NA
-
Ostomy Simulation for Patient Education Prior to Urologic Bowel Diversion Surgeries
RECRUITING · NA
-
Novel Post-Surgical Incision Management to Prevent Ostomy Complications
RECRUITING · NA
-
Ostomy Rural Telehealth Training Cancer Survivors
ACTIVE NOT RECRUITING · NA
-
Observational Study of Ostomy Consumers
ACTIVE NOT RECRUITING
-
Assess the Safety and Adhesive Performance of the VIPER System When Compared to Esteem™
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia